These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 25668102)

  • 1. Enhanced antioxidant capacity of dental pulp-derived iPSC-differentiated hepatocytes and liver regeneration by injectable HGF-releasing hydrogel in fulminant hepatic failure.
    Chiang CH; Wu WW; Li HY; Chien Y; Sun CC; Peng CH; Lin AT; Huang CS; Lai YH; Chiou SH; Hung SI; Chang YL; Lan YT; Liu DM; Chien CS; Huo TI; Lee SD; Wang CY
    Cell Transplant; 2015; 24(3):541-59. PubMed ID: 25668102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergistic effects of carboxymethyl-hexanoyl chitosan, cationic polyurethane-short branch PEI in miR122 gene delivery: accelerated differentiation of iPSCs into mature hepatocyte-like cells and improved stem cell therapy in a hepatic failure model.
    Chien Y; Chang YL; Li HY; Larsson M; Wu WW; Chien CS; Wang CY; Chu PY; Chen KH; Lo WL; Chiou SH; Lan YT; Huo TI; Lee SD; Huang PI
    Acta Biomater; 2015 Feb; 13():228-44. PubMed ID: 25463491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reprogramming induced pluripotent stem cells in the absence of c-Myc for differentiation into hepatocyte-like cells.
    Li HY; Chien Y; Chen YJ; Chen SF; Chang YL; Chiang CH; Jeng SY; Chang CM; Wang ML; Chen LK; Hung SI; Huo TI; Lee SD; Chiou SH
    Biomaterials; 2011 Sep; 32(26):5994-6005. PubMed ID: 21658760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improvement of carbon tetrachloride-induced acute hepatic failure by transplantation of induced pluripotent stem cells without reprogramming factor c-Myc.
    Chang HM; Liao YW; Chiang CH; Chen YJ; Lai YH; Chang YL; Chen HL; Jeng SY; Hsieh JH; Peng CH; Li HY; Chien Y; Chen SY; Chen LK; Huo TI
    Int J Mol Sci; 2012; 13(3):3598-3617. PubMed ID: 22489170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation of hepatoprotective activity of induced pluripotent stem cells in the mouse model of liver injury.
    Chiang CH; Chang CC; Huang HC; Chen YJ; Tsai PH; Jeng SY; Hung SI; Hsieh JH; Huang HS; Chiou SH; Lee FY; Lee SD
    J Biomed Biotechnol; 2011; 2011():219060. PubMed ID: 21808596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Corneal repair by human corneal keratocyte-reprogrammed iPSCs and amphiphatic carboxymethyl-hexanoyl chitosan hydrogel.
    Chien Y; Liao YW; Liu DM; Lin HL; Chen SJ; Chen HL; Peng CH; Liang CM; Mou CY; Chiou SH
    Biomaterials; 2012 Nov; 33(32):8003-16. PubMed ID: 22858046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decellularized Liver Extracellular Matrix as Promising Tools for Transplantable Bioengineered Liver Promotes Hepatic Lineage Commitments of Induced Pluripotent Stem Cells.
    Park KM; Hussein KH; Hong SH; Ahn C; Yang SR; Park SM; Kweon OK; Kim BM; Woo HM
    Tissue Eng Part A; 2016 Mar; 22(5-6):449-60. PubMed ID: 26801816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antinecrotic and antiapoptotic effects of hepatocyte growth factor on cholestatic hepatitis in a mouse model of bile-obstructive diseases.
    Li Z; Mizuno S; Nakamura T
    Am J Physiol Gastrointest Liver Physiol; 2007 Feb; 292(2):G639-46. PubMed ID: 17068118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatic differentiation of mouse iPS cells in vitro.
    Iwamuro M; Komaki T; Kubota Y; Seita M; Kawamoto H; Yuasa T; Shahid JM; Hassan RA; Hassan WA; Nakaji S; Nishikawa Y; Kondo E; Yamamoto K; Fox IJ; Kobayashi N
    Cell Transplant; 2010; 19(6):841-7. PubMed ID: 20955659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of acute hepatic injury by a synthetic prostacyclin agonist through hepatocyte growth factor expression.
    Xu Q; Nakayama M; Suzuki Y; Sakai K; Nakamura T; Sakai Y; Matsumoto K
    Am J Physiol Gastrointest Liver Physiol; 2012 Feb; 302(4):G420-9. PubMed ID: 22159278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid hepatic fate specification of adipose-derived stem cells and their therapeutic potential for liver failure.
    Banas A; Teratani T; Yamamoto Y; Tokuhara M; Takeshita F; Osaki M; Kato T; Okochi H; Ochiya T
    J Gastroenterol Hepatol; 2009 Jan; 24(1):70-7. PubMed ID: 18624899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid generation of mature hepatocyte-like cells from human induced pluripotent stem cells by an efficient three-step protocol.
    Chen YF; Tseng CY; Wang HW; Kuo HC; Yang VW; Lee OK
    Hepatology; 2012 Apr; 55(4):1193-203. PubMed ID: 22095466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatic differentiation of mouse iPS cells and analysis of liver engraftment potential of multistage iPS progeny.
    Balasiddaiah A; Moreno D; Guembe L; Prieto J; Aldabe R
    J Physiol Biochem; 2013 Dec; 69(4):835-45. PubMed ID: 23715756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How important is differentiation in the therapeutic effect of mesenchymal stromal cells in liver disease?
    Wang H; Zhao T; Xu F; Li Y; Wu M; Zhu D; Cong X; Liu Y
    Cytotherapy; 2014 Mar; 16(3):309-18. PubMed ID: 24239106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic potential of human induced pluripotent stem cell-derived mesenchymal stem cells in mice with lethal fulminant hepatic failure.
    Moslem M; Valojerdi MR; Pournasr B; Muhammadnejad A; Baharvand H
    Cell Transplant; 2013; 22(10):1785-99. PubMed ID: 23394436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation of high quality of hepatocyte-like cells from induced pluripotent stem cells with Parp1 but lacking c-Myc.
    Huang CS; Lin HC; Lu KH; Wu WW; Yang YC; Yang YP; Chiang CH; Hsieh JH; Chang YL; Lee SD
    J Chin Med Assoc; 2018 Oct; 81(10):871-877. PubMed ID: 30017813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A transcriptomic study suggesting human iPSC-derived hepatocytes potentially offer a better in vitro model of hepatotoxicity than most hepatoma cell lines.
    Gao X; Liu Y
    Cell Biol Toxicol; 2017 Aug; 33(4):407-421. PubMed ID: 28144825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatocyte growth factor incorporated chitosan nanoparticles differentiate murine bone marrow mesenchymal stem cell into hepatocytes in vitro.
    Pulavendran S; Rajam M; Rose C; Mandal AB
    IET Nanobiotechnol; 2010 Sep; 4(3):51-60. PubMed ID: 20726671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transplantation of a human iPSC-derived hepatocyte sheet increases survival in mice with acute liver failure.
    Nagamoto Y; Takayama K; Ohashi K; Okamoto R; Sakurai F; Tachibana M; Kawabata K; Mizuguchi H
    J Hepatol; 2016 May; 64(5):1068-1075. PubMed ID: 26778754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatocyte growth factor promotes liver regeneration induced by transfusion of bone marrow mononuclear cells in a murine acute liver failure model.
    Jin SZ; Meng XW; Sun X; Han MZ; Liu BR; Wang XH; Pei FH
    J Hepatobiliary Pancreat Sci; 2011 May; 18(3):397-405. PubMed ID: 21076985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.